Onconetix, Inc.
ONCO
$4.00
-$0.10-2.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.93M | 2.52M | 1.87M | 1.46M | 758.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.93M | 2.52M | 1.87M | 1.46M | 758.90K |
| Cost of Revenue | 1.01M | 1.47M | 2.60M | 2.30M | 1.70M |
| Gross Profit | 911.90K | 1.06M | -732.10K | -837.50K | -938.20K |
| SG&A Expenses | 6.97M | 9.03M | 15.03M | 16.66M | 16.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.11M | 10.66M | 17.59M | 19.03M | 19.35M |
| Operating Income | -6.19M | -8.13M | -15.72M | -17.56M | -18.60M |
| Income Before Tax | -57.04M | -59.74M | -51.74M | -53.21M | -45.82M |
| Income Tax Expenses | -923.60K | -1.05M | -139.80K | -83.40K | -134.20K |
| Earnings from Continuing Operations | -56.12 | -58.69 | -51.60 | -53.12 | -45.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.12M | -58.69M | -51.60M | -53.12M | -45.68M |
| EBIT | -6.19M | -8.13M | -15.72M | -17.56M | -18.60M |
| EBITDA | -5.66M | -7.40M | -15.07M | -17.11M | -18.35M |
| EPS Basic | -591.75 | -546.31 | -252.01 | -- | -- |
| Normalized Basic EPS | -118.92 | -113.39 | -121.62 | -- | -- |
| EPS Diluted | -591.75 | -546.31 | -252.01 | -- | -- |
| Normalized Diluted EPS | -118.92 | -113.39 | -121.62 | -- | -- |
| Average Basic Shares Outstanding | 1.64M | 1.42M | 1.32M | -- | -- |
| Average Diluted Shares Outstanding | 1.64M | 1.42M | 1.32M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |